ki:elements
ki:elements, founded in 2017 as a spin-off from the German Research Center for Artificial Intelligence, specializes in speech-based digital biomarkers. The company leverages artificial intelligence to develop non-invasive, cost-effective solutions for monitoring and screening various pathologies through speech analysis. Their flagship product, the Mili platform, facilitates the collection and analysis of speech data in real-world medical applications, enhancing patient compliance and accessibility. Collaborating with leading pharmaceutical companies and clinical research teams, ki:elements has established a strong market position with numerous scientific publications, showcasing their innovative approach to improving patient care and diagnostics.
ki:elements
ki:elements, founded in 2017 as a spin-off from the German Research Center for Artificial Intelligence, specializes in speech-based digital biomarkers. The company leverages artificial intelligence to develop non-invasive, cost-effective solutions for monitoring and screening various pathologies through speech analysis. Their flagship product, the Mili platform, facilitates the collection and analysis of speech data in real-world medical applications, enhancing patient compliance and accessibility. Collaborating with leading pharmaceutical companies and clinical research teams, ki:elements has established a strong market position with numerous scientific publications, showcasing their innovative approach to improving patient care and diagnostics.